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Abstract
Background Kabuki syndrome (KS) is a Mendelian
disorder, characterised by short stature, facial
dysmorphisms and developmental delay and/or intel-
lectual disability. Clariﬁcation of the neurocognitive
proﬁle in KSmay provide directions for education and
treatment interventions for KS. Previous studies on
cognitive functioning in KS are scarce and have
mainly focused on the general level of intelligence.
The few more extensive studies suggested weaknesses
in language skills, visuoconstruction, perceptual rea-
soning and speed of information processing. Other
relevant domains such as memory, executive func-
tioning and social cognition have not been studied yet.
Method This is the ﬁrst study in which cognitive
functioning within multiple domains is systematically
explored in 29 participants with KS (age range:
5–48 years) and compared to both norm groups
(healthy population) and an appropriate control
group of 15 individuals with other genetic syndromes
(age range: 6–28 years).
Results Compared to the norm groups of the cognitive
test manuals, as expected, participants with KS show a
weaker performance on all cognitive tests. Comparison
with the more appropriate genetic control group
indicates weaknesses in visuoconstruction and visual
memory and no weaknesses in planning, cognitive
ﬂexibility or social cognition. Verbal memory seems to
be a relative strength.
Conclusions Individuals with KS suffer from speciﬁc
weaknesses in visuoconstruction, in addition to their
intellectual disability/developmental delay. These
impairments in visuoconstruction plausibly result
from problems in visual perceptual processing, which
highlight the importance of the use of auditory cues
instead of visual cues in targeted educational support
and psychosocial interventions.
Keywords case–control study, cognition, contextual
neuropsychology, Kabuki syndrome, KMT2D,
neurodevelopmental disorder
Introduction
The neurodevelopmental Mendelian disorder
Kabuki syndrome (KS; OMIM #147920) was ﬁrst
described in 1981 by two independent research
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groups (Kuroki et al. 1981; Niikawa et al. 1981). It is
caused by heterozygous mutations in the lysine-
speciﬁc methyltransferase 2D (KMT2D) gene (OMIM
#602113) (Ng et al. 2010) or the lysine-speciﬁc
demethylase 6A (KDM6A) gene (OMIM #300867)
(Lederer et al. 2012; Miyake et al. 2013). Although
the current prevalence is unknown, an earlier study
indicated a prevalence of 1 in 32 000 new-born
infants in Japan (Niikawa et al. 1988). KS is
characterised by developmental delay and/or intel-
lectual disability (ID), short stature and typical cra-
niofacial features such as long palpebral ﬁssures with
an eversion of the lower eyelid, long dense eyelashes
and arched eyebrows. People with KS frequently
have microcephaly, congenital heart defects, urinary
tract anomalies, skeletal abnormality, recurrent up-
per airway infections, fetal ﬁnger pads and abnor-
mality in the dermatoglyphic pattern (Philip et al.
1992; Schrander-Stumpel et al. 1994; Adam and
Hudgins 2005; Bögershausen & Wollnik 2013).
Furthermore, the syndrome is associated with
hearing and vision impairments. Hearing difﬁculties
are probably a result of the frequently occurring
middle ear infections in KS. Although severe visual
impairments are rare, 38–61% of the individuals with
KS display ocular abnormalities such as strabismus,
blue sclera, ptosis, coloboma of the iris and
retina and refractive anomalies (Bögershausen &
Wollnik 2013).
Multiple studies describe both structural and
functional anomalies of the brain in KS. Brain
aberrations are generally non-speciﬁc and are
reported in approximately 40% of the individuals.
These comprise mostly agenesis/hypoplasia of the
corpus callosum, but hydrocephalus, cerebellar
anomalies, cortical and central hypoplasia, ventricular
dilatation, generalised brain atrophy, and white
matter abnormalities have been reported as well
(Ben-Omran & Teebi 2005; Li et al. 2011). As for
impairments in brain functioning, epileptic seizures
have been described in 5–36% of the individuals,
mostly characterised as focal, but bilateral convulsive
and myoclonic seizures have also been reported (Li
et al. 2011; Kurahashi et al. 2017; Lehman et al. 2017).
Interictal electroencephalography has most frequently
revealed focal paroxysmal epileptiform discharges in
regions including fronto-central, parietal, fronto-
temporal and temporo-occipital areas. Mixed results
were found for the effects of treatment with
antiepileptic drugs: the majority of people were not
immediately responsive to medication in one study,
whereas one other study reported efﬁcient
pharmacotherapy in 80% of the individuals (Oksanen
et al. 2004; Lodi et al. 2010; Verrotti et al. 2011;
Kurahashi et al. 2017).
The level of intellectual functioning in KS ranges
from severe ID to normal levels of intelligence, with
the majority of the reported individuals displaying a
mild to moderate ID (TIQ range: 35–69;
Bögershausen & Wollnik 2013, Lehman et al. 2017).
Knowledge of the speciﬁc strengths and weaknesses
in cognitive functioning in individuals with KS,
additional to the level of intelligence, is important for
the development of interventions in KS. Targeted
educational support for instance, may be helpful for
people with KS. Understanding the cognitive proﬁle
in KS is essential in order to implement this type of
support in daily practice. Although most studies of
KS include descriptions of developmental delay or
ID, there is a lack of studies that focus on cognitive
functioning in more detail. The few studies that did
include measurements of cognitive functioning only
focused on language abilities (Morgan et al. 2015) and
visuoconstruction (Caciolo et al. 2018), indeed
displaying speciﬁc weaknesses in these domains, or
included a global cognitive screening based on a
battery of standardised intelligence tasks (Mervis et al.
2005; Lehman et al. 2017). Index scores for verbal
comprehension and working memory were found to
be higher in children with KS in the cognitive
screening study than those for perceptual reasoning
and processing speed (Lehman et al. 2017). Although
this study provides hypotheses regarding weaknesses
in perceptual processing, they should ﬁrst be
validated with traditional measures of the domains of
cognitive functioning.
None of the aforementioned cited studies included
a suitable control group to establish possible strengths
and weaknesses in individuals with KS. In these
studies, performances of individuals with KS were
either compared to performances of other people with
KS (e.g. the comparison of a group of individuals with
a genetically conﬁrmed diagnosis to a group with a
clinical suspicion of KS but without the molecular
conﬁrmation) or compared to a norm group of
individuals with average levels of intelligence (the
majority of individuals in norm groups representing
‘the healthy population’). However, a comparison of
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individuals with KS using controls with a similar level
of intelligence is essential for adequate interpretation
of neuropsychological data, as individuals with ID will
likely deviate on all domains of cognitive functioning
compared to controls with average intelligence levels
(e.g. Lezak et al. 2012; Fletcher et al. 2017). Speciﬁc
cognitive weaknesses or potential strengths related to
KS will otherwise remain unnoticed.
Thus, previous studies regarding cognitive
functioning in KS did not include an appropriate
control group nor included important domains of
neurocognitive functioning such as memory and
executive functioning. Therefore, the present study
examines multiple cognitive domains in a substantial
group of participants with KS (n = 28) in order to
clarify the neurocognitive proﬁle of KS. Performances
on measures of intelligence, adaptive functioning,
memory, executive functioning, social cognition and
visuoconstruction in participants with KS will be
compared to both the norm group represented in the
manuals of the cognitive tests and to the performance
of an appropriate control group. The latter consists of
a mixed group of individuals with other genetic




This study included 28 participants with KS (KS
group; 15 male participants; age range: 5–48 years)
and 15 control participants with another genetic
disorder (GC group; seven male participants; age
range 6–28 years). Participants with KS were
recruited for the study by clinical geneticists at the
Dutch expertise centre for KS (Maastricht University
Medical Centre, The Netherlands) and with help
from the Kabuki caretakers network group in the
Netherlands. Table 1 presents the medical character-
istics (ocular problems, hearing problems as well as
brain functioning and psychopharmacotherapy) of the
500
Table 1 Medical characteristics of participants with Kabuki syndrome
Domain n Speciﬁcation
Ocular problems 17 Minor problems successfully compensated by glasses or
disturbed stereoscopic vision/strabism
4 Severe problems: total loss of sight in one eye for all four
participants and for three of them additionally a loss of 50%
in the other eye1, loss of 85% and tube vision in the other
eye1, and nystagmus2
Hearing problems 3 Single sided deafness
7 Minor hearing problems were present without a need
for hearing aids
9 Hearing problems that were successfully compensated
by hearing aids
7 Hearing problems that were not sufﬁciently compensated
by hearing aids. Hearing was however still sufﬁcient for
cognitive assessment
Brain imaging reports - Reports present for three participants; these did not show
any structural anomalies, besides microcephaly in one participant
Possible neural damage as a
result of brain trauma
3 Oxygen shortage during birth 1, cerebrovascular accident 2,
oxygen shortage as a result of low blood sugar 2
Brain functioning 1 History of epileptic seizures, currently in remission with
the use of Depakine
Psychopharmacotherapy 3 Antipsychotics (aripiprazol, risperidon and Dipiperon)
Sleep medication 5 Melatonin
Hormone treatment 9 -
1Participant of the KS-B group.
2Participant of the KS-A group.
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KS group. Individual demographical variables and
genetic aberrations are displayed in Table S1. Not all
participants with KS were able to execute the entire
cognitive assessment. These participants are referred
to as the ‘KS-A’ group (n = 10). The other partici-
pants with KS completed at least the intelligence
battery plus one test of each speciﬁc cognitive do-
main, and they will be referred to as the ‘KS-B’ group
(n = 18). The GC group included a convenience
sample of individuals with other genetic disorders
who visited the expertise centre for rare genetic
neurodevelopmental disorders (Radboud University
Medical Centre, The Netherlands). The study was
conducted according to the Declaration of Helsinki
and approved by the Central Committee on Research
Involving Human Subjects region Arnhem-Nijmegen
(NL43187.091.13) with written informed consent ob-
tained from all participants, or their legal
representatives.
Materials and procedure
To facilitate participation, individuals were visited at
their homes for the assessment. Testing was
performed by a trained and experienced (>4 years)
psychologist and took place in two visits of
approximately 4 h, in which breaks were provided
based on the individual needs of each participant. To
measure adaptive functioning, primary caregivers of
the participants were interviewed, using the Vineland-
Z (Dutch version of the Vineland Adaptive Behavior
Scales Survey Form; Sparrow et al. 1984). Adaptive
functioning refers to the conceptual, social and
practical skills that have been learned by people in
order to function in everyday life (American
Association on Intellectual and Developmental
Disabilities 2018). The Vineland-Z total level of
adaptive functioning is expressed in a developmental
age. Secondly, a measure of visual and motor abilities
as well as visuoconstruction was included (Beery–
Buktenica Developmental Test of Visual-Motor
Integration; Beery VMI; Beery & Beery 2004).
Intelligence was measured with the Wechsler Adult
Intelligence Scale-IV-NL (WAIS-IV-NL, Dutch
version of the WAIS-IV; Wechsler 2008; Wechsler
2012) for adults, or the WISC-III-NL (Dutch version
of the WISC-III; Wechsler 1991; Wechsler 2005) for
children. Cognitive ﬂexibility and planning were
assessed by the Intra/Extradimensional shifting task
(Cambridge Neuropsychological Test Automated
Battery, CANTAB®) [Cognitive assessment
software] 2018), Key search task and Zoo map task
(both part of the Behavioural Assessment of the
Dysexecutive Syndrome battery; Wilson et al. 1996;
Emslie et al. 2003). Furthermore, memory
functioning was measured by the Rey Auditory Verbal
Learning Test (RAVLT; Schmand et al. 2012,
Osterrieth 1944), Paired Associates Learning test
(PAL, CANTAB®) and Pattern Recognition
Memory test (PRM, CANTAB®). As for social
cognition, performance was assessed by the Dutch
Theory of Mind test-Revised (Steerneman 2009). All
tests are commonly used in a variety of international
neuropsychological studies. For a more extensive
description of the tests, see Table S2.
Statistical analysis
SPSS version 22 for Windows was used for all
statistical analyses. First, mean developmental age
scores were calculated based on the norm group in the
manual of the VABS, to describe adaptive functioning
in the total KS sample as well as for both KS groups
(A and B) separately. Secondly, in order to explore
the more extended cognitive proﬁle, performances of
the KS-B group on the Wechsler scales,
intra/extradimensional shifting test, Key search task,
Zoo map task, RAVLT, PAL, PRM, Theory of Mind
test-Revised, emotion recognition and Beery were
compared to the results of norm groups described in
the test manuals (via transformation of raw scores into
standardised scores). Finally, cognitive test
performances of the KS-B group were compared to
those of the GC group. Although a general linear
model repeated measures would have been the
preferred choice for this design, this was not feasible
due to a lack of power as a result of the relatively small
sample size compared to the large number of
dependent variables. The use of this statistical test
would therefore not be informative in this sample.
Instead, Cohen’s d was calculated for all differences in
cognitive test performances between both groups
(Cohen 1992; Lee 2016).
Results
Table 2 displays the means and standard deviations
for adaptive functioning in the total KS group and for
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the KS-A and KS-B groups separately. A large
difference between chronological and developmental
age was present in all three groups. Furthermore, the
mean developmental age is substantially higher in the
KS-B group compared to the KS-A group, in
accordance with the fact that the KS-B group was able
to complete more (complex) cognitive tasks.
Individual intelligence scores and levels of adaptive
functioning of participants with KS are displayed in
Table S1.
For the comparison of the KS-B group with healthy
individuals, Table 3 presents the mean differences
(IQ and T-scores) between participants with KS and
the available norm groups for all cognitive tests. As
expected, the KS-B group showed a weaker
performance on all of these tests. The mean
performance on the cognitive domains ranged
between 1.2 and 2.9 standard deviations below the
healthy population. Weakest performances were
present in the domains of intelligence and
visuoconstruction.
Table 4 displays the mean raw scores and effect
sizes for the comparison of the results of the KS-B
and GC group. The general level of intelligence for
the GC group (M = 66.6, SD = 13.7) was higher than
for the KS-B group (M = 55.6, SD = 10.1; Cohen’s
d = .92). Furthermore, visuoconstruction was
weaker in the KS-B group (Beery VMI: M = 13.7,
SD = 3.6; Beery Visual: M = 17.2, SD = 4.1; Beery
Motor: M = 14.9, SD = 6.3) compared to the GC
group (Beery VMI: M = 19.1, SD = 4.9; Cohen’s
d = 1.29; Beery Visual: M = 21.6, SD = 4.5;
Cohen’s d = 1.05; Beery Motor: M = 21.1,
SD = 5.3; Cohen’s d = 1.10). As for memory
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Table 2 Chronological age and developmental age for Kabuki syndrome groups
KS total KS-A KS-B
N (male
participants)
28 (15) 10 (7) 18 (8)
M SD Range M SD Range M SD Range
Chronological age 1 206.4 133.4 63–577 145.9 159.5 63–577 240.1 107.0 72–461
Developmental age 2 61.9 38.7 13–145 29.6 13.5 13–49 79.78 36.5 25–145
1Age in months.
2Based on normative means of the Vineland Z, in months.
Table 3 Cognitive performances in KS-B group compared to the norm groups of the test manuals
N Devination from the norm group (in SD) Classiﬁcation
Intelligence WAIS-IV/WISC-III 1 18 2.96 Low
Memory RAVLT immediate recall 1,2 18 1.09 Low average
RAVLT delayed recall 1,2 17 1.61 Below average
Executive functioning Key search 1 16 1.2 Low average
Zoo map 1 1 15 1.36 Below average
Zoo map 2 1 15 1.56 Below average
Social cognition ToM test-R 1,2 16 1.66 Below average
Visuoconstruction Beery VMI 1 18 2.97 Low
1Normative means corrected for age.
2Maximum age of the normative means was 12 (RAVLT, ToM test-R) or 16 (Key search, Zoo map) years of age.
Key search, Zoo map 1 and Zoo map 2 are subtests of the Behavioural Assessment of the Dysexecutive Syndrome. Beery VMI, Beery–Buktenica De-
velopmental Test of Visual-Motor Integration; ToM test-R, Theory of Mind test-Revised; RAVLT, Rey Auditory Verbal Learning Test; WAIS-IV, Wechsler
Adult Intelligence Scale-Fourth Edition; WISC-III, Wechsler Intelligence Scale Children-Third Edition.
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functioning, mixed results were found. Weaknesses in
performances were found on two tests of visual
memory in the KS-B group (PRM:M = 8.1, SD = 2.9;
PAL:M = 5.6, SD = 1.9) compared to the GC group
(PRM:M = 9.7, SD = 1.9; Cohen’s d = .68; PAL:
M = 6.6, SD = 1.6; Cohen’s d =.59). While a slightly
higher performance was present in the KS-B group for
a task that taps into verbal memory (RAVLT
immediate recall: KS-B:M = 37.4, SD = 10.1; GC:
M = 33.5, SD = 11.0; Cohen’s d = .38). As for other
domains of cognitive functioning, there were no
relevant differences between the KS-B and GC group
in planning, executive functioning or social cognition
(.21 < Cohen’s d < .25).
Discussion
This is the ﬁrst case–control study to explore multiple
domains of cognitive functioning in individuals with
KS. Performances of intelligence, executive
functioning, memory, social cognition and
visuoconstruction in participants with KS (KS-B
group) were ﬁrst compared to the results of norm
groups represented in the manuals of the different
cognitive tests. As expected, performances of the
KS-B group were lower than those of norm groups
consisting of healthy people, for all cognitive tests.
Participants within the KS-B group deviated most
strongly on the domains of intelligence and
visuoconstruction, in contrast to a relatively small
deviation for the domains of executive functioning,
memory and social cognition. These results could
indicate that these last domains are relatively
unaffected in participants with KS, in spite of their
intellectual impairment. Performances of the KS-B
group were then compared to those of a more
appropriate control group, to further sustain these
ﬁndings. The latter group consisted of participants
with other genetic syndromes associated with
ID/developmental delay.
A lower mean level of intelligence was present for
the KS-B group compared to the GC group.
Nonetheless, there were no substantial differences in
performances between the KS-B group and PGC
group on domains of executive functioning, verbal
memory and social cognition. The latter result was
also in accordance with the comparison between the
KS-B and the norm group, which might indicate a
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size2N M 1 SD 1 N M 1 SD 1
Intelligence TIQ 18 55.6 10.1 22 66.6 13.7 11.0 .92
Executive functioning IED 17 6.8 2.4 20 7.0 2.4 .2 .09
Key search 17 4.9 4.5 20 3.8 4.4 1.1 .25
Zoo map 1 16 2.4 6.0 19 1.3 4.7 1.1 .21
Zoo map 2 16 2.8 6.1 19 3.2 5.4 .4 .07
Memory RAVLT immediate recall 18 37.4 10.1 21 33.5 11.0 3.9 .38
RAVLT delayed recall 17 6.5 3.4 20 6.2 3.2 .3 .09
PRM 17 8.1 2.9 20 9.7 1.9 1.6 .68
PAL 17 5.6 1.9 20 6.6 1.6 1.0 .59
Social cognition ToM test-R 16 25.4 6.0 21 24.8 5.6 .6 .11
Visuoconstruction Beery VMI 18 13.7 3.6 18 19.1 4.9 5.4 1.29
Beery Visual 18 17.2 4.1 18 21.6 4.5 4.4 1.05
Beery Motor 18 14.9 6.3 18 21.1 5.3 6.2 1.10
1Raw performance scores.
2Cohen’s d effect sizes of .2, .5 and .8 represent, respectively, a small, medium and large effect.
Key search, Zoo map 1 and Zoo map 2 are subtests of the Behavioural Assessment of the Dysexecutive Syndrome; Beery VMI, Beery–Buktenica De-
velopmental Test of Visual-Motor Integration; IED, intra/extradimensional shift test (CANTAB); PAL, Paired Associates Learning test (CANTAB); PRM,
Pattern Recognition Memory test (CANTAB); RAVLT, Rey Auditory Verbal Learning Test; ToM test-R, Theory of Mind test-Revised; TIQ, total intelli-
gence quotient.
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relative strength of these cognitive domains in
individuals with KS. Furthermore, lower performances
in the KS-B group compared to the GC group were
present for the domains of visuoconstruction and visual
memory. As verbal memory was relatively unaffected in
the KS-B group, the visual memory problemsmay have
been a result of weaknesses in visual processing
interfering with imprinting, rather than a result of
genuine memory problems.
Multiple factors could have contributed to the
weaknesses found in visuoconstruction in the KS-B
group. First of all, it may have been a result of ocular
anomalies. As the majority of participants had only
minor ocular problems, which probably did not
interfere with cognitive test performances, group
results may plausibly have been affected by only three
of the participants (with more severe ocular
problems). Their performances did not deviate
substantially more from the group mean than the
performances of other participants in the KS-B group,
which suggests only a minor negative inﬂuence on the
total group performances. Secondly, lower scores on
tasks measuring visuoconstruction could have been
the result of primary deﬁcits in motor responses, for
instance due to hypotonia or developmental delay of
ﬁne motor skills, which have often been reported in
participants with KS (Bögershausen and Wollnik
2013). A weaker performance was indeed found on a
task that taps explicitly into ﬁne motor functioning
(Beery Motor). However, these weaknesses did not
entirely explain the differences in visuoconstruction
between the KS-B and GC group, which argues for
additional cognitive weaknesses. The
visuoconstruction problems may have been a
reﬂection of the initial differences in intellectual
functioning between the KS-B and GC groups,
although they seem to be too speciﬁc to be explained
by the differences in intellectual functioning entirely.
Thus, it is plausible that our results reﬂect speciﬁc
weaknesses in primarily visual perceptive processing
(and as a result also in visuoconstruction), which is in
line with previous ﬁndings of weaker performances of
participants with KS on tasks that tap into visual
perceptive processing (Lehman et al. 2017; Caciolo
et al. 2018). Future studies may focus on the
development of specialised interventions for these
visual processing problems in KS.
The strengths of the current study lie in the
extensiveness of the cognitive assessment and the
inclusion of a genetic control group, which enables
the observation of speciﬁc strengths and weaknesses
related to KS. Not all participants were able to
execute the entire assessment, which resulted in an
exclusion of these individuals for the analyses of
cognitive performance. As expected, results on
measures of adaptive functioning indicated that
developmental age was higher in the KS-B group
compared to the KS-A group. Because the results on
cognitive tasks were solely based on performances of
the KS-B group, ﬁndings may therefore reﬂect an
overestimation of the capabilities of the total
population of individuals with KS.
This study was executed parallel to another study
on cognitive functioning in KS (Harris et al. 2019).
Design, data collection and interpretation of the
results of that study, however, were performed
independently and none of the participants was
included in both samples. Interestingly also in this
complementary study, weaknesses in similar domains
were notiﬁed, further emphasising our ﬁndings.
In conclusion, this study indicates that individuals
with KS suffer from speciﬁc weaknesses in
visuoconstruction and visual memory, additional to
general ID. The visuoconstruction problems that
were demonstrated may well reﬂect a primary
problem in visual perceptual processing, which may
also be the underlying cause of the observed
weaknesses in visual memory. Contrary to the use of
visual symbols, often applied in the daily practice of
patient care for individuals with ID, the results
presented here highlight the importance of the use of
auditory cues instead of or additional to visual cues, in
targeted educational support and psychosocial
interventions for individuals with KS.
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